Skip to main content
Publications
Moehler M, Wyrwicz L, Chen C, Davenport E, Wang J, Nathani R, Kondo K, Elimova E. Health-related quality of life (HRQOL) in patients with advanced gastric, gastroesophageal junction, or esophageal adenocarcinoma cancer (GC/GEJC/EAC): 36-month results of CheckMate 649 nivolumab plus chemotherapy (N+C) vs (C). Poster presented at the 2024 German Cancer Congress (Deutscher Krebskongress); February 21, 2024. Berlin, Germany. [abstract] Oncol Res Treat. 2024; 41(Supple 1):65. Previously presented at the 2023 ASCO Annual Meeting.
O'Connor G, Pinero Casas M, Basagana X, Lopez Vicente M, Davand P, Torrent M, Martinez-Murciano D, Garcia-Esteban R, Marinelli M, Sunyer J, Julvez J. Corrigendum to "Television viewing duration during childhood and long-association with adolescent neuropsychological outcomes" [Prev. Med. Rep. 4 (2016) 447-452.]. Prev Med Rep. 2021 Mar;21:101305. doi: 10.1016/j.pmedr.2020.101305
Todenhofer T, Fizazi K, Shore ND, Tammela T, Kuss I, Le Barre M-A, Mohammed AF, Odom D, Bartsch J, Snapir A, Sarapohja T, Smith MR. Impact of darolutamide (DARO) on pain and quality of life (QoL) in patients (PTS) with nonmetastatic castrate-resistant prostate cancer (NMCRPC). Poster presented at the 2020 German Cancer Congress; February 2020. [abstract] Oncol Res Treat. 2020 Feb; 43(Suppl 1):154-5. Previously presented at the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting.
O'Connor G, Pinero Casas M, Basagana X, Vicente ML, Davand P, Torrent M, Martinez-Murciano D, Garcia-Esteban R, Marinelli M, Sunyer J, Julvez J. Television viewing duration during childhood and long-association with adolescent neuropsychological outcomes. Prev Med Rep. 2016 Aug 15;4:447-52. doi: 10.1016/j.pmedr.2016.08.013